Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes: Implication of the p80 tumor necrosis factor receptor

Diabetes

Volumn 47, Issue 4, 1998, Pages 515-522

  Liu, Li Sen ^a   Spelleken, Martina ^a   Röhrig, Karin ^a   Hauner, Hans ^a   Eckel, Jörgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOCYTE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BIOLOGICAL TRANSPORT; CELLS, CULTURED; FEMALE; GLUCOSE; HUMANS; INSULIN; PHOSPHOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041009626     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.4.515     Document Type: Article

References (45)

1. Old LJ: Tumor necrosis factor (TNF), Science 230:630-632, 1985
2. Beutler B, Cerami A: The biology of cachectin/TNF-α: a primary mediator of the host response. Annu Rev Immunol 7:625-655, 1989
3. Grunfeld C, Feingold KR: The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-150, 1991
4. Vilcek J, Lee TH: Tumor necrosis factor new insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316, 1991
5. McCall JL, Tuckey JA, Parry BR: Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 79:1361-1363, 1992
6. Van der Poll T, Romijn JA, Enden E, Borm JJJ, Buller HR, Sauerwein HR, Sauerwein HP: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:E457-E465, 1991
7. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Hemdon DN, Wolfe RR: Differentiation between septic and postburn insulin resistance. Metabolism 38:983-989, 1989
8. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
9. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
10. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
11. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
12. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058, 1993
13. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science 271:665-668, 1996
14. Kanety H, Feinstem R, Papa MZ, Hemi R, Karasik R, Karasik A: Tumor necrosis factor-α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). J Biol Chem 270:23780-23784, 1995
15. Kanety H, Hemi R, Papa MZ, Karasik A: Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897, 1996
16. Guo D, Dormer DB: Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271:615-618, 1996
17. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 61:351-359, 1990
18. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023, 1990
19. Vandenabeele P, Declerq W, Beyaert R, Fiers W: Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 5:392-399, 1995
20. Tartaglia LA, Goeddel DV: Tumor necrosis factor receptor signaling: a dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J Biol Chem 267:4304-4307, 1992
21. Wiegmann K, Schütze S, Kampen E, Himmler A, Machleidt T, Krönke M: Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 267:17997-18001, 1992
22. Tartaglia LA, Weber RF, Flgari IS, Reynolds C, Palladino MAJ, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296, 1991
23. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM: Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022, 1996
24. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
25. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 95:2111-2119, 1995
26. Sagizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF-α by human muscle: relationship to insulin resistance, J Clin Invest 97:1111-1116, 1996
27. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
28. Hauner H, Petruschke T, RUSS M, Eckel J: Effects of tumour necrosis factor alpha (TNF-α) on glucose transport and lipid metabolism of newly differentiated human fat cells in cell culture. Diabetologia 38:764-771, 1995
29. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131, 1990
30. RUSS M, Wichelhaus A, Uphues I, Kolter T, Eckel J: Photoaffmity labelling of cardiac membrane GTP-binding proteins in response to insulin. Eur J Biochem 219:325-330, 1994
31. Kolter T, Uphues I, Eckel J: Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 273:E59-E67, 1997
32. Wichelhaus A, Russ M, Petersen S, Eckel J: G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am J Physiol 267:H548-H555, 1994
33. Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endocr Rev 16:117-142, 1995
34. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R: Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 171:415-426, 1990
35. Hohmann H, Brockhaus M, Baeuerle PA, Remy R, Kolbeck R, van Loon APGM: Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κKB. J Biol Chem 265:22409-22417, 1990
36. Vandenabeele P, Declerc W, Vercammen V, Van de Craen M, Loetscher H, Brockhaus M, Lesslauer W, Fiers W: Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T-cell hybridoma. J Exp Med 176:1015-1024, 1992
37. Heydrick SJ, Gautier N, Olichon-Berthe C, Van Obberghen E, Le Marchand-Brustel Y: Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocate from gold thioglucose obese mice. Am J Physiol 268:E604-E612, 1995
38. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Häring H: Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance. J Clin Invest 97:1471-1477, 1996
39. Tartaglia L, Pennica D, Goeddel DV: Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548, 1993
40. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834, 1991
41. Totpal K, Agarwal S, Agarwal BB: Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells. Cancer Res 52:2557-2562, 1992
42. Stephens JM, Lee J, Pilch, PF: Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-976, 1997
43. Tartaglia LA, Rothe M, Hu Y-F, Goeddel DV: Tumor necrosis factors cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213-216, 1993
44. Heller RA, Krönke M: Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9, 1994
45. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455, 1997